Otulfi 130 mg

Otulfi 130 mg is a medicine authorised by Swissmedic under authorisation number 70295. The authorisation holder is Fresenius Kabi (Schweiz) AG. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 24 April 2026 and the authorisation is limited until 23 April 2031. ATC code L04AC05 places the medicine in the group Immunosuppressants.

  • Dispensing category B
  • Authorisation number 70295
  • ATC L04AC05
  • Biotechnological medicines
Authorisation data
Authorisation number70295
NameOtulfi 130 mg
Full nameOtulfi 130 mg, Konzentrat zur Herstellung einer Infusionslösung
Authorisation holderFresenius Kabi (Schweiz) AG
Medicinal product codeBiotechnological medicines
Dispensing categoryB · Prescription only
ATC codeL04AC05
First authorisation24 April 2026
Authorisation validity23 April 2031
Strengths
No.NameDispensing categoryAuthorisation date
1Otulfi 130 mg, Konzentrat zur Herstellung einer InfusionslösungB24 April 2026

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Durchstechflasche(n)L04AC0507.15.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Otulfi 130 mg authorised in Switzerland?

Yes. Otulfi 130 mg is authorised by Swissmedic under authorisation number 70295, data as of 01 September 2026. The authorisation is limited until 23 April 2031.

Which dispensing category does Otulfi 130 mg have?

Otulfi 130 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Otulfi 130 mg?

The authorisation holder is Fresenius Kabi (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com